查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824320

2025年女性健康体检全球市场报告

Womens Health Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年女性健康诊断市场规模将强劲成长，2029年将达到534.5亿美元，复合年增长率为9.7%。预测期内的成长可归因于生殖健康问题发病率的上升、女性人口老化、个人化医疗的进步、基因检测作用的不断扩大以及对非传染性疾病的日益关注。预测期内的主要趋势包括更年期管理、预防和早期发现、整体性和多样性、疫情主导的数位化以及环境和生活方式的考虑。

未来五年9.7%的成长预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致日本和比利时开发的人类乳突病毒去氧核糖核酸检测和自动阴道镜设备的价格上涨，从而导致子宫颈癌检测延迟和筛检计画成本增加，进而阻碍美国的预防保健。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，贸易摩擦的影响也可能更为广泛。

预计女性健康诊断市场的成长将受到慢性病盛行率上升的推动。慢性病是一种持续性疾病，通常进展缓慢，需要持续的管理和照护。此类疾病盛行率的上升催生了对女性用健康诊断的需求，这对于识别和监测乳癌、子宫颈癌和生殖系统疾病等疾病至关重要。例如，根据美国国家医学图书馆的数据，到2050年，美国岁及以上患有至少一种慢性病的人数预计将达到1.4266亿，这使得女性慢性病患病率的上升成为女性用健康诊断市场增长的关键驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球女性健康：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球女性健康体检市场：成长率分析
  • 全球女性健康体检市场表现：规模与成长，2019-2024
  • 全球女性健康体检市场预测：2024-2029年及2034年规模与成长
  • 全球女性健康体检：潜在市场总量（TAM）

第六章 市场细分

  • 全球女性健康体检市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 配件和耗材
  • 诊断测试
  • 诊断设备
  • 全球女性健康体检市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 骨质疏鬆症检测
  • 卵巢癌筛检（OVC）
  • 子宫颈癌筛检
  • 乳癌筛检
  • 妊娠和生育能力测试
  • 产前基因筛检和基因带原检测
  • 传染病检查
  • 性行为感染传染病（STD）检测
  • 超音波
  • 全球女性健康体检市场：按最终用户、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断和影像中心
  • 居家护理
  • 其他最终用户
  • 全球女性健康检查市场：按配件和耗材（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 检测套组
  • 采样装置
  • 试剂
  • 控製材料
  • 全球女性健康诊断市场：细分市场、诊断测试类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 血液检查
  • 影像检查
  • 基因检测
  • 荷尔蒙测试
  • 全球女性健康体检市场：依诊断设备（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 影像设备
  • 侵入性诊断设备
  • 非侵入性诊断设备
  • 监控设备

第七章 区域和国家分析

  • 全球女性健康体检市场：按地区、结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球女性健康体检市场：按国家/地区、实际结果和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 女性健康体检市场：竞争格局
  • 女性健康体检市场：公司简介
    • Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Siemens Healthineers
  • Abbott Laboratories
  • BioMerieux SA
  • Hologic Inc.
  • PerkinElmer Inc.
  • Cardinal Health Inc.
  • Alere Inc.
  • Carestream Health Inc.
  • Mankind Pharma Limited
  • Procter & Gamble Co.
  • Trinity Biotech plc
  • Medgyn Products Inc.
  • URIT Medical Electronic Co. Ltd
  • Sonic Healthcare Limited
  • Fujifilm Holdings Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年女性健康体检市场：提供新机会的国家
  • 2029年女性健康体检市场：细分领域蕴藏新机会
  • 2029年女性健康体检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24605u

Women's health diagnostics encompass medical examinations and procedures employed to assess and diagnose a range of health conditions and diseases specifically impacting women. These diagnostic measures play a crucial role in early identification of health issues, enabling timely and appropriate treatment and management to enhance outcomes and overall quality of life.

The primary categories of women's health diagnostics include accessories and consumables, diagnostic tests, and diagnostic devices. Accessories and consumables encompass a variety of supplementary items and materials utilized in diagnostic procedures tailored to women's health. These items contribute to improving the accuracy, convenience, and effectiveness of diagnostic tests and examinations for women. Applications of these accessories and consumables span diverse areas such as osteoporosis testing, ovarian cancer testing (OVC), cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening, carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound testing. These diagnostics find application across various end users, including hospitals and clinics, diagnostic and imaging centers, homecare settings, and other relevant end-user contexts.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The women's health diagnostics market research report is one of a series of new reports from The Business Research Company that provides women's health diagnostics market statistics, including women's health diagnostics industry global market size, regional shares, competitors with a women's health diagnostics market share, detailed women's health diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the women's health diagnostics industry. This women's health diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The womens health diagnostics market size has grown strongly in recent years. It will grow from $34.63 billion in 2024 to $36.88 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased awareness and education, risen female population over 40, government initiatives for women's health, preventive healthcare trends, changed lifestyles and health concerns.

The womens health diagnostics market size is expected to see strong growth in the next few years. It will grow to $53.45 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising incidence of reproductive health issues, growing aging population of women, advancements in personalized medicine, expanding role of genetic testing, increased focus on non-communicable diseases. Major trends in the forecast period include menopause management, preventive and early detection, inclusivity and diversity, pandemic-driven digitalization, environmental and lifestyle considerations.

The forecast of 9.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. preventive care by inflating prices of Human Papillomavirus Deoxyribonucleic acid tests and automated colposcopy devices developed in Japan and Belgium, resulting in delayed cervical cancer detection and higher screening program expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the women's health diagnostics market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases are enduring conditions that typically progress gradually, necessitating ongoing management and care. The escalating prevalence of these conditions creates a heightened demand for women's health diagnostics, essential for identifying and monitoring diseases such as breast cancer, cervical cancer, and reproductive disorders. For example, data from the National Library of Medicine, a US-based agency, revealed that by 2050, the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million, underscoring how the rise in chronic diseases among women is a key driver for the growth of the women's health diagnostics market.

The increasing demand for personalized medicine is poised to drive the growth of the women's health diagnostics market. Personalized medicine involves utilizing knowledge about an individual's genes or proteins to prevent, detect, or treat diseases. This approach enables healthcare providers to develop treatment plans tailored to a woman's unique genetic, molecular, and clinical profile, often involving targeted therapies based on genetic markers or specific biomarkers. In 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition, a US-based professional membership organization. Hence, the increasing demand for personalized medicine is a significant driver for the growth of the women's health diagnostics market.

The prevailing trend gaining momentum in women's health diagnostics is technological advancements in personalized health solutions. Major players within the women's health diagnostics market are directing their efforts towards technological innovations and the development of new products to enhance diagnostic capabilities and maintain their market position. For example, in February 2022, FemTec Health, Inc., a US-based women's health company, introduced a direct-to-consumer (D2C) brand named Awesome Woman, offering personalized health and wellness products for women across various life stages. The brand employs AI, machine learning, and customer data encompassing genomics, genetics, and health history to create customized offerings. These personalized subscription boxes may include vitamins, probiotics, and at-home tests tailored to individual needs. Users can choose specific health focus areas such as vaginal and urinary health, reproductive health, hormone balance, and beauty. Additionally, the service provides telehealth support to enhance the overall customer experience and accessibility to healthcare professionals.

Prominent companies in the women's health diagnostics market are concentrating on product innovations, exemplified by the development of premium ultrasound systems, to reinforce their market standing. A premium ultrasound system is an advanced medical imaging device designed for detailed and high-quality imaging of internal structures in the human body, specifically tailored for obstetrics and gynecology within Samsung's HERA platform. In February 2023, Samsung's digital radiography and ultrasound business unveiled the HERA W10 Elite, a cutting-edge women's health ultrasound system. This system is equipped with a suite of artificial intelligence (AI) tools and clinical applications, signifying a significant advancement in the diagnostic experience for women's health. The HERA W10 Elite features advanced capabilities such as MV-Flow for displaying blood flow intensity, BiometryAssist for convenient fetal growth parameter measurement, and precise analytics to aid clinicians in diagnosis.

In October 2024, Hologic, a US-based medical technology company, acquired Gynesonics, Inc. for an undisclosed sum. This acquisition is intended to enhance Hologic's minimally invasive solutions for women's health, specifically targeting the treatment of symptomatic uterine fibroids and heavy menstrual bleeding. By integrating the Sonata system, Hologic aims to improve patient outcomes and provide GYN surgeons with a wider array of treatment options. This strategic decision underscores Hologic's commitment to innovation and growth in women's healthcare. Gynesonics is a US-based company that focuses on developing innovative medical technologies for women's health, emphasizing non-invasive treatments for uterine fibroids and providing diagnostic solutions.

Major companies operating in the womens health diagnostics market include Becton Dickinson And Company, F. Hoffmann-La Roche AG, General Electric Company, Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Abbott Laboratories, BioMerieux SA, Hologic Inc., PerkinElmer Inc., Cardinal Health Inc., Alere Inc., Carestream Health Inc., Mankind Pharma Limited, Procter & Gamble Co., Trinity Biotech plc, Medgyn Products Inc., URIT Medical Electronic Co. Ltd, Sonic Healthcare Limited, Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Genomic Health Inc., Invitae Corporation, Natera Inc., QIAGEN N.V., Opko Health Inc., Sysmex Corporation, Exact Sciences Corporation, Foundation Medicine Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc.

North America was the largest region in the women's health diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global women's health diagnostics market report during the forecast period. The regions covered in the womens health diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the womens health diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The women's health diagnostics market includes revenues earned by entities by providing women's health diagnostics, including pregnancy tests, breast imaging equipment, and hormone level tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Womens Health Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on womens health diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for womens health diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The womens health diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Accessories And Consumables; Diagnostic Tests; Diagnostic Devices
  • 2) By Application: Osteoporosis Testing; Ovarian Cancer Testing (OVC); Cervical Cancer Testing; Breast Cancer Testing; Pregnancy And Fertility Testing; Prenatal Genetic Screening And Carrier Testing; Infectious Disease Testing; Sexually Transmitted Diseases (STD) Testing; Ultrasound Tests
  • 3) By End User: Hospitals And Clinics; Diagnostic And Imaging Centers; Homecare; Other End Users
  • Subsegments:
  • 1) By Accessories And Consumables: Test Kits; Sample Collection Devices; Reagents; Control Materials
  • 2) By Diagnostic Tests: Blood Tests; Imaging Tests; Genetic Tests; Hormonal Tests
  • 3) By Diagnostic Devices: Imaging Devices; Invasive Diagnostic Devices; Non-Invasive Diagnostic Devices; Monitoring Devices
  • Companies Mentioned: Becton Dickinson And Company; F. Hoffmann-La Roche AG; General Electric Company; Koninklijke Philips N.V.; Quest Diagnostics Incorporated; Siemens Healthineers; Abbott Laboratories; BioMerieux SA; Hologic Inc.; PerkinElmer Inc.; Cardinal Health Inc.; Alere Inc.; Carestream Health Inc.; Mankind Pharma Limited; Procter & Gamble Co.; Trinity Biotech plc; Medgyn Products Inc.; URIT Medical Electronic Co. Ltd; Sonic Healthcare Limited; Fujifilm Holdings Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Myriad Genetics Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; Danaher Corporation; Genomic Health Inc.; Invitae Corporation; Natera Inc.; QIAGEN N.V.; Opko Health Inc.; Sysmex Corporation; Exact Sciences Corporation; Foundation Medicine Inc.; Laboratory Corporation of America Holdings; NeoGenomics Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Womens Health Diagnostics Market Characteristics

3. Womens Health Diagnostics Market Trends And Strategies

4. Womens Health Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Womens Health Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Womens Health Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Womens Health Diagnostics Market Growth Rate Analysis
  • 5.4. Global Womens Health Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Womens Health Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Womens Health Diagnostics Total Addressable Market (TAM)

6. Womens Health Diagnostics Market Segmentation

  • 6.1. Global Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Accessories And Consumables
  • Diagnostic Tests
  • Diagnostic Devices
  • 6.2. Global Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Osteoporosis Testing
  • Ovarian Cancer Testing (OVC)
  • Cervical Cancer Testing
  • Breast Cancer Testing
  • Pregnancy And Fertility Testing
  • Prenatal Genetic Screening And Carrier Testing
  • Infectious Disease Testing
  • Sexually Transmitted Diseases (STD) Testing
  • Ultrasound Tests
  • 6.3. Global Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic And Imaging Centers
  • Homecare
  • Other End Users
  • 6.4. Global Womens Health Diagnostics Market, Sub-Segmentation Of Accessories And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Kits
  • Sample Collection Devices
  • Reagents
  • Control Materials
  • 6.5. Global Womens Health Diagnostics Market, Sub-Segmentation Of Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Imaging Tests
  • Genetic Tests
  • Hormonal Tests
  • 6.6. Global Womens Health Diagnostics Market, Sub-Segmentation Of Diagnostic Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Devices
  • Invasive Diagnostic Devices
  • Non-Invasive Diagnostic Devices
  • Monitoring Devices

7. Womens Health Diagnostics Market Regional And Country Analysis

  • 7.1. Global Womens Health Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Womens Health Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Womens Health Diagnostics Market

  • 8.1. Asia-Pacific Womens Health Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Womens Health Diagnostics Market

  • 9.1. China Womens Health Diagnostics Market Overview
  • 9.2. China Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Womens Health Diagnostics Market

  • 10.1. India Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Womens Health Diagnostics Market

  • 11.1. Japan Womens Health Diagnostics Market Overview
  • 11.2. Japan Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Womens Health Diagnostics Market

  • 12.1. Australia Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Womens Health Diagnostics Market

  • 13.1. Indonesia Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Womens Health Diagnostics Market

  • 14.1. South Korea Womens Health Diagnostics Market Overview
  • 14.2. South Korea Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Womens Health Diagnostics Market

  • 15.1. Western Europe Womens Health Diagnostics Market Overview
  • 15.2. Western Europe Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Womens Health Diagnostics Market

  • 16.1. UK Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Womens Health Diagnostics Market

  • 17.1. Germany Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Womens Health Diagnostics Market

  • 18.1. France Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Womens Health Diagnostics Market

  • 19.1. Italy Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Womens Health Diagnostics Market

  • 20.1. Spain Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Womens Health Diagnostics Market

  • 21.1. Eastern Europe Womens Health Diagnostics Market Overview
  • 21.2. Eastern Europe Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Womens Health Diagnostics Market

  • 22.1. Russia Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Womens Health Diagnostics Market

  • 23.1. North America Womens Health Diagnostics Market Overview
  • 23.2. North America Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Womens Health Diagnostics Market

  • 24.1. USA Womens Health Diagnostics Market Overview
  • 24.2. USA Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Womens Health Diagnostics Market

  • 25.1. Canada Womens Health Diagnostics Market Overview
  • 25.2. Canada Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Womens Health Diagnostics Market

  • 26.1. South America Womens Health Diagnostics Market Overview
  • 26.2. South America Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Womens Health Diagnostics Market

  • 27.1. Brazil Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Womens Health Diagnostics Market

  • 28.1. Middle East Womens Health Diagnostics Market Overview
  • 28.2. Middle East Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Womens Health Diagnostics Market

  • 29.1. Africa Womens Health Diagnostics Market Overview
  • 29.2. Africa Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Womens Health Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Womens Health Diagnostics Market Competitive Landscape
  • 30.2. Womens Health Diagnostics Market Company Profiles
    • 30.2.1. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Womens Health Diagnostics Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Abbott Laboratories
  • 31.3. BioMerieux SA
  • 31.4. Hologic Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. Cardinal Health Inc.
  • 31.7. Alere Inc.
  • 31.8. Carestream Health Inc.
  • 31.9. Mankind Pharma Limited
  • 31.10. Procter & Gamble Co.
  • 31.11. Trinity Biotech plc
  • 31.12. Medgyn Products Inc.
  • 31.13. URIT Medical Electronic Co. Ltd
  • 31.14. Sonic Healthcare Limited
  • 31.15. Fujifilm Holdings Corporation

32. Global Womens Health Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Womens Health Diagnostics Market

34. Recent Developments In The Womens Health Diagnostics Market

35. Womens Health Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Womens Health Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Womens Health Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Womens Health Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer